ArticlePloS one2012

Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.

Mark A A Claassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.